Zacks Investment Research on MSN
Here's why you should retain Masimo stock in your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...
Zacks Investment Research on MSN
Owlet vs. Masimo: Which medical monitoring stock is the better buy?
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by ...
Masimo announced that its CEO Joe Kiani informed the board of directors that he has stepped down from his post. He was replaced by board member Michelle Brennan on an interim basis. The change is ...
Why Masimo Is On Investors’ Radar Today Masimo (MASI) has drawn fresh attention after recent share price moves, with the stock last closing at $137.33. That price sits against a mixed performance ...
Masimo Corporation MASI, on Friday, announced a partnership with Google. The tie-up aims to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Google ...
Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2025 on Monday. Despite the robust preliminary results, the company’s shares lost nearly 0.4% till yesterday ...
The Relative Strength (RS) Rating for Masimo stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 78. This exclusive rating from Investor's Business Daily measures share price ...
The medical technology specialist, known for its monitoring devices, named an interim CEO. This followed the resignation of its existing chief. Masimo announced that its CEO Joe Kiani informed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results